Post COVID-19 vaccine Guillain Barre Syndrome
Pakistan Journal of Neurological Sciences · 2022
DOI: 10.56310/pjns.v17i02.174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Neurological Sciences, 2022. Verfasst von Soban Khan und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The Guillain Barre Syndrome (GBS) is an acute immune mediated progressive polyneuropathy having an acute monophasic illness leading to paralysis. The clinical features are progressive ascending symmetrical muscle weakness that may lead to respiratory failure. Diagnosis is based upon clinical presentation and is supported by a lumbar puncture with CSF analysis demonstrating albumin cytological dissociation and electrophysiological studies. Our patient presented to us with progressive ascending paralysis after receiving COVID 19 vaccine.
Zitieren
APA
Khan, S., Khalil, M., Waqar, Z., Khan, S., & Jan, Z. (2022). Post COVID-19 vaccine Guillain Barre Syndrome. Pakistan Journal of Neurological Sciences. https://doi.org/10.56310/pjns.v17i02.174
Vancouver
Khan S, Khalil M, Waqar Z, Khan S, Jan Z. Post COVID-19 vaccine Guillain Barre Syndrome. Pakistan Journal of Neurological Sciences. 2022. doi:10.56310/pjns.v17i02.174
BibTeX
@article{Khan2022,
author = {Khan, Soban and Khalil, Maryam and Waqar, Zaid and Khan, Sajid and Jan, Zakir},
title = {Post COVID-19 vaccine Guillain Barre Syndrome},
journal = {Pakistan Journal of Neurological Sciences},
year = {2022},
doi = {10.56310/pjns.v17i02.174}
}
EUVIMED